✦ LIBER ✦

Repeat treatment of Rheumatoid Arthritis patients with a murine anti-intercellular adhesion molecule 1 monoclonal antibody

✍ Scribed by Arthur F. Kavanaugh; Hendrik Schulze-Koops; Laurie S. Davis; Peter E. Lipsky

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 543 KB
Volume: 40
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.1780400511

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of refractory rheumatoid arthr

Treatment of refractory rheumatoid arthritis with a monoclonal antibody to intercellular adhesion molecule 1

✍ Arthur F. Kavanaugh; Laurie S. Davis; Lisa A. Nichols; Stephen H. Norris; Robert 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 763 KB

Treatment of refractory rheumatoid arthr

Treatment of refractory rheumatoid arthritis with a chimeric ANTI-CD4 monoclonal antibody

✍ Larry W. Moreland; Parks W. Pratt; Ralph P. Bucy; Bettie S. Jackson; Janie W. Fe 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 505 KB

Decrease in cellularity and expression o

Decrease in cellularity and expression of adhesion molecules by anti–tumor necrosis factor α monoclonal antibody treatment in patients with rheumatoid arthritis

✍ Paul P. Tak; Peter C. Taylor; Ferdinand C. Breedveld; Tom J. M. Smeets; Mohamed 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 882 KB

Increased levels of circulating intercel

Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis

✍ John J. Cush; Robert Rothlein; Herbert B. Lindsley; Elizabeth A. Mainolfi; Peter 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 456 KB 👁 2 views

A randomized controlled trial with an an

A randomized controlled trial with an anti-CCL2 (anti–monocyte chemotactic protein 1) monoclonal antibody in patients with rheumatoid arthritis

✍ Jasper J. Haringman; Danielle M. Gerlag; Tom J. M. Smeets; Dominique Baeten; Fil 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 2 views

## Abstract ## Objective Chemokines such as CCL2/monocyte chemotactic protein 1 (MCP‐1) play a key role in leukocyte migration and are potential targets in the treatment of chronic inflammatory disorders. The objective of this study was to evaluate the effects of human anti–CCL2/MCP‐1 monoclonal a

Intercellular adhesion molecule 1 underl

Intercellular adhesion molecule 1 underlies the functional heterogeneity of synovial cells in patients with rheumatoid arthritis: Involvement of cell cycle machinery

✍ Yoshiya Tanaka; Masashi Nomi; Koichi Fujii; Stefan Hübscher; Akihiko Maruo; Shig 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 879 KB